For the Treatment of Moderate to Severe Alzheimer’s Disease, a Combination Treatment That Delays Nursing Home Admission Would Earn Higher Patient Share in the U.S. Than Europe

WALTHAM, Mass., Feb. 17, /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer’s disease, a combination therapy that delays nursing home admission at 19 months

Popularity: unranked [?]

Share this Post:
Digg Google Bookmarks reddit Mixx StumbleUpon Technorati Yahoo! Buzz DesignFloat Delicious BlinkList Furl

No Responses to “For the Treatment of Moderate to Severe Alzheimer’s Disease, a Combination Treatment That Delays Nursing Home Admission Would Earn Higher Patient Share in the U.S. Than Europe”

Leave a Reply:

Name (required):
Mail (will not be published) (required):
Website:
Comment (required):
XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash playerPlugin by wpburn.com wordpress themes